Navigation Links
ThalesNano, Inc. Forms Collaborations with Leading US Universities based on the Award Winning H-Cube(R) and H-Cube Midi(TM)
Date:10/6/2008

Expanding chemistry and introducing continuous process chemistry to the

next generation of chemists among the goals

BUDAPEST, Hungary, LONDON and PRINCETON, N.J., Oct. 6 /PRNewswire/ -- ThalesNano, Inc. today announced that it has signed agreements with a number of academic organizations including the Scripps Research Institute, the University of California, San Francisco, Boston University, Temple University and the University of Texas at Arlington. These institutions join the top 20 pharmaceutical companies, who have all deployed ThalesNano's H-Cube.

The H-Cube Hydrogenation Reactor is a bench-top standalone device, uniquely combining continuous-flow chemistry with endogenous hydrogen generation and a disposable catalyst cartridge system. At about a foot wide, and with the flexibility to use a vastly extended range of conditions compared to traditional techniques without any safety concerns, the H-Cube system is ideally suited to educational and to academic research laboratories.

Professor Phil Baran of the Scripps Research Institute explains, "The H-Cube has already had a dramatic effect on our research and that of several groups at Scripps. We believe the H-Cube will soon be as essential as an HPLC in the toolkit of a modern organic chemistry laboratory."

Added Dr. Chris O'Brien of the University of Texas at Arlington, "My group now take for granted that they can perform high pressure, high temperature hydrogenations with ease in a fume hood. To do these reactions conventionally requires substantial safety precautions and training. As testament to the H-Cube Midi's ease-of-use and scalability, high pressure hydrogenations are now routinely performed by undergraduates to yield 10s of grams of final product. H-Cube technology is a must-have for any synthetic laboratory."

"We believe that collaboration with leading universities will serve the entire chemistry community," said Dr. Laszlo Urge, CEO of ThalesNa
'/>"/>

SOURCE ThalesNano, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. World Leader in Bench Top Flow Chemistry Instruments ThalesNano, Inc. Introduces an Industry First Seminar Series
2. World Leader in Bench-Top Flow Chemistry Instruments ThalesNano, Inc. Closes Funding Round
3. Abeome Forms First Class Scientific Advisory Board
4. Satyam Forms Partnership with Sciformix to Provide Comprehensive Drug Safety Management
5. Neogen Forms Mexican Subsidiary
6. BioStorage Technologies Forms Scientific Advisory Board with Leading Life Science Experts
7. American Oriental Bioengineering Forms Science and Technology Advisory Committee
8. IC Sciences Announces Launch of ICS Advisory Services Intellectual Property Platforms Available Through ICSciences Alliance
9. Agrenco Informs Sale of Biodiesel at ANP Auction
10. Caliper Life Sciences Forms Alliance With Horizon Discovery to Provide Enhanced Solutions for Cancer Research Based on Isogenic Cell Lines
11. International Federation of Clinical Chemistry Forms Partnership With the Labs Are Vital(TM) Initiative

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... Intarcia Therapeutics, Inc. deliv...S® continuous delivery of exenatide) program ...Annual Diabetes Technology Meeting in San Francisc...n/prnh/20050301/SFTU126LOGO ) ,, Continuous S...ers Plasma Glucose, HbA1c and Reduces Weight in a ...
(Date:11/5/2009)... 5 GenVec, Inc. (Nasdaq:... the third quarter ended September 30, 2009. GenVe...hare) for the three months ended September 30, 200...r share) in the comparable quarter of 2008. For th...et loss was $14.1 million ($0.15 per share), compa...
(Date:11/5/2009)...wswire-FirstCall/ -- Imagenetix, Inc. (OTC Bulleti...er, President and CEO of Imagenetix, will be prese...RO Conference on Thursday, December 3rd, at 10:30 ...out LD MICRO ,, LD MICRO is a by-invitation onl...ued companies in the micro-cap space. Since 2002, ...
(Date:11/5/2009)...Newswire-FirstCall/ -- Transgenomic, Inc. (OTC Bul...ts for the quarter ended September 30, 2009. The C...bles that follow. ,, Third Quarter 2009 ,,....01 per share for the third quarter of 2009 as com... for the third quarter of 2008. ,, Net sales w...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
...Pa., May 18 ViroPharma Incorporated (Nasdaq: VP...ional Organization for Rare Disorders (NORD) Annua...terase inhibitor (human)) to market for a rare and...E). , , HAE is a rare, severely debilitating, lif...ncy of C1 inhibitor, a human plasma protein. Patie...
...gazine Pays Tribute to America,s Top Research Scie...air of Prana,s Biotechnology Research & Develo...May 18 Dr. Rudy Tanzi, Prana Biotechnology,s (Nas...tor of the Genetics and Aging Research Unit at the...ses , will be featured in a six-page photo spread...
... Will be Reported from Phase 2 Studies Evaluating ...tal Cancer and Gastrointestinal Stromal Tumors (GI...ls, Inc. (Nasdaq: KERX ) today announced that fo...,s Akt-inhibitor for cancer, were accepted for pre...he 45th Annual Meeting of the American Society of ...
Other Biology Technology:ViroPharma Incorporated Honored by the National Organization for Rare Disorders 2ViroPharma Incorporated Honored by the National Organization for Rare Disorders 3ViroPharma Incorporated Honored by the National Organization for Rare Disorders 4ViroPharma Incorporated Honored by the National Organization for Rare Disorders 5ROCK STARS OF SCIENCE: Prana's Co-Founding Scientist, Rudy Tanzi Teams up with Star-Powered Cast in GQ Photoshoot 2ROCK STARS OF SCIENCE: Prana's Co-Founding Scientist, Rudy Tanzi Teams up with Star-Powered Cast in GQ Photoshoot 3Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology 2Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology 3Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology 4
(Date:11/4/2009)...- Lowly bacteria, it turns out, hold the power to ... around the world clean up toxic waste on test sit...y RDX, were invented back in World War II and have...se high-energy compounds are often used to propel ...f TNT. , But with increased knowledge of their...
(Date:11/4/2009)....J., Oct. 20 Quest Diagn...ding provider of diagnostic testing, information a...ended September 30, 2009, income from continuing o...ed share, from $160 million, or $0.81 per diluted ...rd quarter results were reduced by a $0.03 per sha...
(Date:11/4/2009)...Calif., Oct. 23 GenVault Corporati...nagement for genomic discovery, medicine and ident...., GenVault,s President and CEO, will be presentin...n October 26th and 27th in La Jolla, CA. ,, Dur...verview of the company together with recent custom...
Breaking Biology News(10 mins):Genomic research will enable greener cleanup of military explosive test sites 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Prebiotics Add Heart Health Bone Health and Digestive Health Support to Research Proven Cancer Fighting Ability 58335 1Prebiotics Add Heart Health Bone Health and Digestive Health Support to Research Proven Cancer Fighting Ability 58335 2synergIT Presents at VMworld 2009 in San Francisco 58333 1synergIT Presents at VMworld 2009 in San Francisco 58333 2synergIT Presents at VMworld 2009 in San Francisco 58333 3RCRC Independent Review Board Announces DHHS Research Oversight 58331 1RCRC Independent Review Board Announces DHHS Research Oversight 58331 2
...r deterioration seen in muscular dystrophy can be ...y for their effects against cancer, a Burnham Inst... the potential use of these drugs, called histone ...and repair of dystrophic muscles, thereby counteri...t mouse models of muscular dystrophy. Led by Burnh...
...new project being developed by Central Queensland ... surgery patients around the country could soon ha...t of their own home rather than having to travel t... University’s Rockhampton campus are developing an...ple who have had heart surgery to see if it improv...
...technical advance in the study of the complex rece...researchers at the University of California, San D...the signaling pathways that impact activation of a...ing and to the thrombosis that occurs in heart att...re-build the signaling pathway that regulates acti...
Other Biology News:Experimental cancer drugs counter muscle deterioration seen in muscular dystrophy 2UCSD researchers create roadmap to integrin activation 2UCSD researchers create roadmap to integrin activation 3
...nal [6331] to Salmonella typhimurium The genus Sa...eae. The genus is composed of Gram-negative bacill...Salmonellae possess 3 major antigens; the "H" or f... antigen (part of the LPS moiety) and the "Vi" or ...
...W4 liquid handling system from Molecular Devices p...l in one instrument. The system handles a variety ...6-, 384- and 1536-welland is the first to handle 1...optimized to dispense from four different channels...
...sodium pyruvate, 50 mg/L streptomycin sulfate, 100...lcium chloride, and magnesium chloride. The use of...is generally attributed to early workers in the fi...f inorganic salts designed to maintain contractili...
Horizontal Laminar Flow Work Station from Terra Universal, Inc.
Biology Products: